C-125/10

Merck & Co. Inc.

This case raises the following question which has been sent to the Court of Justice for a preliminary ruling:

Can a supplementary protection certificate for medicinal products be granted if the period of time between the filing of the application for the basic patent and the date of first authorisation for marketing in the Community is shorter than five years?